[11C]BIO-1819578
N/A
Report date: 2023/10/13 13:48:27
NME
Base Information
Drug Name[11C]BIO-1819578
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiogen Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A